RdRp inhibitor (Trawsfynydd Therapeutics)

N/A

Report date: 2025/06/11 10:35:07
NME

Base Information

Drug NameRdRp inhibitor (Trawsfynydd Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTraws Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTraws Pharma Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A